J.M. Forbes & Co’s Ginkgo Bioworks DNA Stock Holding History

J.M. Forbes & Co’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$12.5M	Sell	977,371 -22,540	-2%	-$184K	0.94%	34
2026 Q2	$9.9M	Sell	999,911 -28,480	-3%	-$238K	0.78%	42
2026 Q1	$6.3M	Sell	1,028,391 -12,050	-1%	-$100K	0.53%	54
2025 Q4	$8.65M	Sell	1,040,441 -19,900	-2%	-$214K	0.7%	42
2025 Q3	$15.5M	Sell	1,060,341 -16,900	-2%	-$202K	1.28%	23
2025 Q2	$12.1M	Sell	1,077,241 -17,323	-2%	-$134K	1.11%	31
2025 Q1	$6.24M	Buy	1,094,564 +392,832	+56%	+$4M	0.6%	52
2024 Q4	$6.89M	Buy	701,732 +576,732	+461%	+$4.94M	0.66%	47
2024 Q3	$1.02M	Buy	+125,000	New	+$1.25M	0.1%	79

Other funds holding DNA

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

J.M. Forbes & Co's DNA Position: Q3 2026 in Review

J.M. Forbes & Co reduced its Ginkgo Bioworks (DNA) stake by 2.3% in Q3 2026, selling an estimated $184K and leaving 977,371 shares worth $12.5M. The position accounts for 0.94% of the portfolio, ranked #34.

J.M. Forbes & Co first reported a position in DNA in Q3 2024 and has held it in 9 quarters since. The position peaked at $15.5M in Q3 2025. 76 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

J.M. Forbes & Co held 977,371 shares of Ginkgo Bioworks worth $12.5M as of Q3 2026.
J.M. Forbes & Co sold 22,540 Ginkgo Bioworks shares in Q3 2026, an estimated $184K.
Ginkgo Bioworks made up 0.94% of J.M. Forbes & Co's portfolio in Q3 2026, its #34 holding.
J.M. Forbes & Co first reported a position in Ginkgo Bioworks in Q3 2024 and has held it in 9 quarters since.
J.M. Forbes & Co's Ginkgo Bioworks position peaked at $15.5M in Q3 2025.
76 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on J.M. Forbes & Co's 13F filing for Q3 2026, filed 16 Oct 2026.